Loading data
XLONasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 43.77 m USD | 6.34 m USD | — | — | — |
| Research and development expense | 56.04 m USD | 41.21 m USD | 52.14 m USD | 59.2 m USD | 51.19 m USD |
| Operating profit | -41.98 m USD | -60.58 m USD | -79.13 m USD | -89.15 m USD | -75.04 m USD |
| Profit before tax | -35.04 m USD | -58.24 m USD | — | — | — |
| Income tax expense | 0 USD | — | — | — | — |
| Net income (reported basis) | -35 m USD | -58.2 m USD | -76.4 m USD | -88.2 m USD | -75.8 m USD |
| Basic earnings per share | -4.19 USD/share | -15.24 USD/share | -2.78 USD/share | -3.22 USD/share | -13.52 USD/share |
| Diluted earnings per share | -4.19 USD/share | -15.24 USD/share | -2.78 USD/share | -3.22 USD/share | -13.52 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.